Quarterly report pursuant to Section 13 or 15(d)

Additional Cash Flow Information (Tables)

v3.20.2
Additional Cash Flow Information (Tables)
9 Months Ended
Sep. 30, 2020
Supplemental Cash Flow Information [Abstract]  
Schedule of Net Changes in Components of Operating Assets and Liabilities The following table provides information regarding the net changes in working capital (in thousands):
Nine Months Ended September 30,
2020 2019
Accounts receivable $ 1,991  $ (3,374)
Prepaid expenses and other current assets 6,995  1,653 
Accounts payable (25) (4,192)
Accounts payable due to related parties (Note 7) 1,360  — 
Accrued liabilities 3,155  18,379 
Other, net (1,748) (1,950)
Net changes in working capital $ 11,728  $ 10,516 
Schedule of Supplemental Disclosure of Cash Flow Information The following table provides supplemental disclosure of cash flow information (in thousands):
Nine Months Ended September 30,
2020 2019
Non-cash accruals of property, plant and equipment and other non-current assets $ 7,955  $ 7,875 
Non-cash settlement of Final Payment Fee (Note 9) 8,539  — 
Future proceeds from sale of Magellan Petroleum UK —  4,940 
Tradable equity securities —  3,705 
Non-cash settlement of withholding taxes associated with the 2019 and 2018 bonus and vesting of certain awards, respectively 878  6,686 
Non-cash settlement of the 2019 and 2018 bonus, respectively 4,344  18,396 
    The statement of cash flows for the nine months ended September 30, 2020, reflects approximately $78.5 million and $2.1 million in non-cash movements related to the 2019 Term Loan and the Replacement Warrant, respectively.
    The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets that sum to the total of such amounts shown in the Condensed Consolidated Statements of Cash Flows (in thousands):
Nine Months Ended September 30,
2020 2019
Cash and cash equivalents $ 77,947  $ 91,057 
Non-current restricted cash 3,441  4,300 
Total cash, cash equivalents and restricted cash shown in the statements of cash flows $ 81,388  $ 95,357